相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular signature of interleukin-22 in colon carcinoma cells and organoid models
Ina Rudloff et al.
TRANSLATIONAL RESEARCH (2020)
Safety, pharmacokinetics, and biomarkers of F-652, a recombinant human interleukin-22 dimer, in healthy subjects
Kai-Yang Tang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Randomized Phase I Healthy Volunteer Study of UTTR1147A (IL-22Fc): A Potential Therapy for Epithelial Injury
Michael E. Rothenberg et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Innate lymphoid cell type 3-derived interleukin-22 boosts lipocalin-2 production in intestinal epithelial cells via synergy between STAT3 and NF-B
Maarten Coorens et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Four Decades After the Discovery of Regenerating Islet-Derived (Reg) Proteins: Current Understanding and Challenges
Zijing Chen et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Role of JAM-A tyrosine phosphorylation in epithelial barrier dysfunction during intestinal inflammation
Shuling Fan et al.
MOLECULAR BIOLOGY OF THE CELL (2019)
Interleukin 22 Expands Transit-Amplifying Cells While Depleting Lgr5+ Stem Cells via Inhibition of Wnt and Notch Signaling
Juan-Min Zha et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
Daniela Parada Venegas et al.
FRONTIERS IN IMMUNOLOGY (2019)
IL22 Inhibits Epithelial Stem Cell Expansion in an Ileal Organoid Model
Bailey Zwarycz et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)
Pre-clinical and translational pharmacology of a human interleukin-22 IgG fusion protein for potential treatment of infectious or inflammatory diseases
Eric G. Stefanich et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Cooperation between the bacterial-derived short-chain fatty acid butyrate and interleukin-22 detected in human Caco2 colon epithelial/carcinoma cells
Malte Bachmann et al.
BIOFACTORS (2017)
IL-22 Increases Permeability of Intestinal Epithelial Tight Junctions by Enhancing Claudin-2 Expression
Yaya Wang et al.
JOURNAL OF IMMUNOLOGY (2017)
Lactobacillus delivery of bioactive interleukin-22
Yin Lin et al.
MICROBIAL CELL FACTORIES (2017)
Mend Your Fences The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease
Eva Martini et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2017)
IL-22 Upregulates Epithelial Claudin-2 to Drive Diarrhea and Enteric Pathogen Clearance
Pei-Yun Tsai et al.
CELL HOST & MICROBE (2017)
Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration
Caroline A. Lindemans et al.
NATURE (2015)
Immunopathogenesis of IBD: current state of the art
Heitor S. P. de Souza et al.
Nature Reviews Gastroenterology & Hepatology (2015)
Butyrate modulates bacterial adherence on LS174T human colorectal cells by stimulating mucin secretion and MAPK signaling pathway
Tae-Hwan Jung et al.
NUTRITION RESEARCH AND PRACTICE (2015)
Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays
Kelli L. VanDussen et al.
GUT (2015)
Hes1 promotes the IL-22-mediated antimicrobial response by enhancing STAT3-dependent transcription in human intestinal epithelial cells
Tatsuro Murano et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Immune-epithelial crosstalk at the intestinal surface
Nadine Wittkopf et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Gut microbiota-generated metabolites in animal health and disease
Won-Jae Lee et al.
NATURE CHEMICAL BIOLOGY (2014)
IL-22 is related to development of human colon cancer by activation of STAT3
Runqiu Jiang et al.
BMC CANCER (2013)
Short-Chain Fatty Acids Activate AMP-Activated Protein Kinase and Ameliorate Ethanol-Induced Intestinal Barrier Dysfunction in Caco-2 Cell Monolayers
Elhaseen E. Eamin et al.
JOURNAL OF NUTRITION (2013)
Mucosal healing in inflammatory bowel diseases: a systematic review
Markus F. Neurath et al.
GUT (2012)
Interleukin-22 Protects Intestinal Stem Cells from Immune-Mediated Tissue Damage and Regulates Sensitivity to Graft versus Host Disease
Alan M. Hanash et al.
IMMUNITY (2012)
Defective IL10 Signaling Defi ning a Subgroup of Patients With Inflammatory Bowel Disease
Bernadette Begue et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
DMBT1 Is a Novel Gene Induced by IL-22 in Ulcerative Colitis
Hirokazu Fukui et al.
INFLAMMATORY BOWEL DISEASES (2011)
Memory/effector (CD45RBlo) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology
Masahito Kamanaka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Involvement of the IL-22/REG Iα axis in ulcerative colitis
Akira Sekikawa et al.
LABORATORY INVESTIGATION (2010)
TNF-α-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells
Irina Treede et al.
BMC GASTROENTEROLOGY (2009)
Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17
Melba Munoz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Butyrate Enhances the Intestinal Barrier by Facilitating Tight Junction Assembly via Activation of AMP-Activated Protein Kinase in Caco-2 Cell Monolayers
Luying Peng et al.
JOURNAL OF NUTRITION (2009)
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Toshiro Sato et al.
NATURE (2009)
Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier
Luying Peng et al.
PEDIATRIC RESEARCH (2007)
Cytokine-induced upregulation of NF-κB, IL-8, and ICAM-1 is dependent on colonic cell polarity:: implication for PKCδ
S Vallee et al.
EXPERIMENTAL CELL RESEARCH (2004)
分享论文
